Enanta Pharmaceuticals
ENTA
#8276
Rank
NZ$0.59 B
Marketcap
NZ$20.34
Share price
0.96%
Change (1 day)
-0.25%
Change (1 year)

EPS for Enanta Pharmaceuticals (ENTA)

EPS in 2026 (TTM): NZ-$4.19

According to Enanta Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$4.33. In 2025 the company made an earnings per share (EPS) of NZ-$5.75 an increase over its 2024 EPS that were of NZ-$8.89.

EPS history for Enanta Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$4.19-27.12%
2025NZ-$5.75-35.35%
2024NZ-$8.89
2021NZ-$8.9472.92%
2020NZ-$5.17-267.44%
2019NZ$3.09-61.35%
2018NZ$7.99147.22%
2017NZ$3.23-460%
2016NZ-$0.90-114.88%
2015NZ$6.03-23.81%
2014NZ$7.92-244.12%
2013NZ-$5.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.00-377.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.43-317.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
NZ$10.51-342.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$28.14-750.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.78-141.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.12-287.55%๐Ÿ‡บ๐Ÿ‡ธ USA